Amanote Research

Amanote Research

    RegisterSign In

Pseudogene BMI1P1 Expression as a Novel Predictor for Acute Myeloid Leukemia Development and Prognosis

Oncotarget - United States
doi 10.18632/oncotarget.10156
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

June 18, 2016

Authors
Ling-Yu ZhouLing-Ling ZhaiJia-Yu YinMinse Evola-Deniz VanessaJiao ZhouJing ZhangXi TangJiang LinJun QianZhao-Qun Deng
Publisher

Impact Journals, LLC


Related search

A 17-Gene-Expression Profile to Improve Prognosis Prediction in Childhood Acute Myeloid Leukemia

Oncotarget
Oncology
2018English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology
Hematology
2012English

SALL1 Expression in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

Prognosis of Patients With a Second Relapse of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

High Expression of Dedicator of Cytokinesis 1 (DOCK1) Confers Poor Prognosis in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

WTAP Is a Novel Oncogenic Protein in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Acute Myeloid Leukemia

JAMA - Journal of the American Medical Association
Medicine
2010English

WTAP Is a Novel Oncogenic Protein in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy